Products for Research Use Only
RegisterLogin

KY-02327

CAT: 0804-HY-124156Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-124156Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KY-02327, a metabolically stabilized KY-02061 analog, is a potent Dishevelled (Dvl) -CXXC5 interaction inhibitor. KY-02327 shows an activating effect on the Wnt/β-catenin pathway, resulting in promotion of osteoblast differentiation[1].
CAS Number
2093407-25-9
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Wnt
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ky-02327.html
Purity
92.62
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C(N1CC(NCCN2CCCCC2)=O)=CC3=C1C=CC(O)=C3)OCC
Molecular Formula
C20H27N3O4
Molecular Weight
373.45
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Kim HY, et al. Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy. EMBO Mol Med. 2016;8 (4) :375-387.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-124764KY-04031
HY-117218KY-04045
HY-167664KY-455
HY-113773KY-9
HY-124745-01KY-05009
HY-U00148-01KY-556
HY-117842KY 234
HY-P99431-01KY-1044
HY-120327-01KY-226
HY-RS07479KY Human Pre-designed siRNA Set A

Alternative Products

CatalogName
BUP02949-01KY-02327
T62436-01KY-02327 acetate
566859-01KY
037653KY, NT (KY, Kyphoscoliosis peptidase)
MBS6314975-01KY, NT (KY, Kyphoscoliosis peptidase) (AP)
BA2865-10KY-05009
T201482-01KY-455
453086-01KY 02111
MBS3610912-01KY-226
MBS7104433-01KY Antibody

Popular Products